Connect with us

CBD

Pure Extracts and Canada House Sign Supply Agreement for Medicinal Cannabis Products

Published

on

Step onto Wall Street with StreetInsider Premium. Request your one-week free trial here.

VANCOUVER, British Columbia and LOUISEVILLE, Québec, June 24, 2021 (GLOBE NEWSWIRE) – Pure Extracts Technologies Corp.. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure extracts“), A herbal extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, and the Canada House Wellness Group (CSE: CHV) (“Canada house“), A fully integrated medical cannabis company (collectively the”Companies“), Are pleased to announce that they have signed a medical care contract (the”approval“). Under the terms of the agreement, Canada House’s wholly owned subsidiary, Abba Medix Corp. (“Degradation“), Will purchase Pure Extracts’ entire line of concentrate products, including CBD, THC, and blended vapes, as well as CBD and THC gums, for sale to its established medical patient base.

“We are excited to partner with Pure Extracts and add their high quality products to Abba’s extensive medical device portfolio. Pure has established itself as one of the leading brands in the country and the ability to bring quality products like this on board is in line with CHV’s strategy to provide the highest quality medical cannabis products to our enrolled patients, especially the veteran community, ”commented Chris Churchill – Smith, CEO of Canada House.

Pure Extracts CEO Ben Nikolaevsky added, “This agreement marks our entry into the medical cannabis space, which will be a significant contributor to sales from the fourth quarter and ramp-up in 2022 on Portal, allowing us to quickly and efficiently expand our stellar line of products of full spectrum oil (FSO) CBD and THC vape products and our blister packaged gum products, including our ultra-potent 100 mg CBD chews, to their patients across Canada. “

ON BEHALF OF THE MANAGEMENT BOARD“Ben Nikolaevsky” Ben NikolaevskyManaging Director and Director

over Pure extracts (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)

Pure Extracts Technology Corp. has a brand new, state-of-the-art processing facility located just 20 minutes north of world famous Whistler, British Columbia. The bespoke facility has been built to the European Union’s GMP standards and aims to export products and formulations, including those currently restricted in Canada, to European jurisdictions where they are legally available. Health Canada granted Pure Extracts its standard processing license on September 25, 2020 under the Cannabis Act. The company’s shares were listed on the Canadian Securities Exchange (CSE) on November 5, 2020.

Learn more at https://pureextractscorp.com/.

For more informations:

Pure Extracts Investor RelationsTel: +1 604 493 2052info@pureextractscorp.com

About the Canada House Wellness Group

Canada House Wellness Group is the parent company of Abba Medix Corp., a licensed manufacturer in Pickering, Ontario that produces high quality medical grade cannabis; IsoCanMed Inc., a licensed producer in Louiseville, Québec that grows premium indoor cannabis and uses the latest vertical aeroponic production methods in its 64,000 square foot manufacturing facility; Canada House Clinics Inc., with clinics across the country working directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex conditions; and Knalysis Technologies, a provider of fully customizable, cloud-based software that connects physician, provider and patient with data that supports medical cannabis treatment.

Canada House Wellness Group’s goal is to become the premier breeder of high quality craft cannabis and provider of cannabinoid therapies targeting the global medical cannabis market. Please visit www.canadahouse.ca or Canada House’s public filings at www.sedar.com.

For more information: Steven Pearce, Vice-President, Legal, Canada House Wellness Group at 289-980-3584.

Cautionary Statement Regarding Forward-Looking InformationThis press release contains forward-looking statements, including statements that affect, but are not limited to, the companies’ clinics, manufacturing and technology businesses, their future plans, the markets, goals, objectives, strategies, intentions, beliefs, expectations and estimates that may be made by use in general of words like “can”, “will”, “could”, “should”, “would”, “likely”, “possible”, “expect”, “intend”, “estimate”, “anticipate”, “believe” , “Plan”, “objective” and “continue” (or the negative of them) and words and expressions of similar meanings. Although the companies believe that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties and should not be relied upon inappropriately. Certain material factors or assumptions have been made in preparing forward-looking statements and actual results could differ materially from those expressed or implied by such statements. The key assumptions used to develop forward-looking information in this press release include, but are not limited to, the cannabis use regulations under the Regulations on Access to Cannabis for Medical Use and the Cannabis Act and Amending the Controlled Drugs and Substances Act, the and Criminal Code and other laws passed by the Federal Government of Canada legalizing cannabis and cannabis-based edibles, vapes, and oils for recreational use on October 17, 2018 and October 17, 2019; Companies’ liquidity and capital resources, including the availability of additional capital resources to fund their activities; Level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key leaders; and the ability to execute strategic plans. For more information about material factors that could cause actual results to differ materially from expectations, as well as material factors or assumptions that are used in preparing forward-looking statements, see the most recent annual and interim financial statements and management discussion of the Companies under “Risks and Uncertainties”. as well as other public disclosure documents filed with Canadian securities regulators. The companies undertake no obligation to publicly update or revise the forward-looking statements contained in this document as a result of new information, future events or for any other reason, except as required by law.

Neither the CSE nor its regulatory service provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this press release.

Source: Pure Extracts Technologies Corp.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

CBD

At 16.27% CAGR, Industrial Hemp Market Accounted for USD 3.91 Bn in 2020 says Brandessence Market Research

Published

on

PUNE, India, December 3, 2021 / PRNewswire / – According to Brandessence Market Research, forecasts for the hemp industry are on promising path to grow at a promising 16.27% CAGR over the 2021-2027 period. The market forecast for industrial hemp estimates that industrial hemp for $ 3.91 billion in 2020. The growing demand for hemp food products, nutraceuticals, beverages, alternative sources of protein and others remain major drivers in regions like North America.

Legalization of marijuana in 18 states in The United States has increased the promise of an already robust growth in the hemp market. At its peak, industrial hemp has come in $ 45-50 per pound in 2018. The Covid-19 crisis has had a negative impact on industrial hemp and slowed demand. The U.S. Department of Agriculture (USDA) estimates that farmers can produce up to 2 to 12 tons of dry logs per acre. Similar estimates are projected in Europewhere farmers produce 3.6 to 8.7 tons per acre. The USDA also estimated that the variable, fixed, and operator costs were based on $ 286 per hectare for hemp fiber, $ 233 for certified seeds and $ 196 for seeds. While those estimates are ancient, the promising new growth from legalizing marijuana in 18 states is a promising new growth engine for the industrial hemp market. The 2018 US Farm Bill, which removed hemp from a controlled substance list, also promises a new opportunity for growers around the world to join the industrial hemp market.

Get a sample copy of it [email protected] https://brandessenceresearch.com/requestSample/PostId/702

Industrial hemp market: an overview

While marijuana-based products have fueled some frenzy for hemp production, these estimates also remain misleading. On the one hand, due to the economic downturn, marijuana sales have not grown as high as initially thought. In addition, conventional uses of industrial hemp, including textiles, paper, rope, clothing, plastics, paints, biofuels, insulation, food, and animal feed. Industrial hemp is also increasingly used in building materials, personal care cosmetics, etc. It is also believed that the traditional uses of hemp in medicine were widespread Asia Pacific, and other regions. In addition, the ban on hemp items led to the destruction of ancient knowledge regarding the use of hemp products. Despite the tremendous damage to its reputation, hemp seeds are widely recognized as a good source of protein, fat, and high nutritional fiber. Similarly, traditional oriental medicine has used hemp for the treatment and prevention of diseases for thousands of years. The growing interest in hemp in major food categories such as nutraceuticals is expected to fuel the growth of the hemp market over the 2021-2028 period. The growing demand for hemp products to treat depression remains a major driver along with several other key benefits of industrial medical hemp.

The USDA also announced crop insurance and incentives such as farm loans for the growth of the hemp market. In the midst of a historic economic downturn, this led to a significant oversupply. However, the USDA and industry experts believe the outlook for the hemp market remains optimistic. For example, the USDA found that hemp production remained at zero in most parts of the US in 2014, while it rose to nearly 90,000 acres in 2018. Likewise, the licensed hemp growers were no more than 300 in 2014, which rose to over 3,500 by 2018.

Segmentation analysis of the Industrial Hemp Market

By product

After application

  • Animal welfare
  • food and drinks
  • paper
  • construction materials
  • personal hygiene
  • textiles
  • automobile
  • furniture

Industrial Hemp Market: Competitive Analysis

The industrial hemp market is a fragmented, competitive, and innovative landscape. As industrial hemp production becomes a new growth opportunity, experimentation with foods, cosmetics, and building materials made from hemp continues to increase. Some of the key players in the industrial hemp market are CBD Biotechnology Co, Marijuana Company of America Inc, Botanical Genetics, LLC, Terra Tech Corp, American Cannabis Company, Inc., LLC Marijuana Company of America Inc. HempMeds Brasil Terra Tech Corp, LLC American Hemp Hemp, Parkland Industrial Hemp Growers Cooperative Ltd., Botanical Genetics, Inc, HempFlax BV Industrial Hemp Manufacturing, Boring Hemp Company Plains Industrial Hemp Processing Ltd. Ecofiber Industries Operations Valley Bio Limited

Get methodology @ https://brandessenceresearch.com/requestMethodology/PostId/702

Industrial Hemp Market: Key Trends

  • Hemp seeds will represent the strongest growth in the hemp market in the near future. Hemp seeds accounted for over 40% of total sales in 2020. The growing demand for hemp seed cake, the demand for hemp oil, and the growing demand for hemp nutraceuticals remain the main drivers of this growth. In addition, hemp oil is growing in a growing range of everyday products, including personal care, foods and beverages, animal feed derivatives, and personal care products.
  • The hemp fiber is expected to continue its promising application in new areas such as paper, home textiles, insulation materials, building materials, auto parts and composites. Hemp fibers are loaded with hemicellulose, with high absorption capacities. These make them ideal for textile applications. This application remains one of the strongest growth areas for hemp manufacturers with new niche growth in areas like the automotive industry. The manufacture of electric vehicles and the increasing demand for mile-long automobiles have led automakers to launch new products to make lightweight automobiles. Hemp remains a growing prospect for new car interiors as well as automotive parts.
  • Hemp weed or shives is a short fiber of wood extracted from industrial humps. This fiber is inexpensive and, thanks to its highly absorbent quality, promises a wide range of uses for new applications such as animal litter. The material promises high absorbency, ideal for soaking animal urine and promises to hold four times its original weight.
  • CBD is gaining traction as an acceptable treatment for clinical depression and anxiety. This research is still in the primary stage and is often in preclinical evidence. However, the research is consistent with the traditional attraction of hemp or CBD properties as neuroprotective, anxiolytic, pain reliever and anti-inflammatory, anti-epileptic, anti-asthmatic and anti-tumor properties. The conventional use of hemp in Asia Pacific as medicine and the increasing use of industrial hemp in the treatment of ailments such as depression, among other things, remains a great promise for the growth of the hemp market.

Industrial Hemp Market: Regional Analysis

The industrial hemp market promises a robust forecast in North America Region. The highest growth is expected for this region in the forecast period. Marijuana legalization remains a promising horizon in this market; with a growing number of people in the US remaining optimistic about recreational use. In addition, research into industrial hemp applications, including medical, nutraceutical, food and cosmetic products, is growing.

Demand for industrial hemp in regions such as the Asia-Pacific region also remains robust. Asia Pacific Home to various regional herbs and promises robust growth for natural food ingredients. The growing demand for industrial hemp in the densely populated region remains a bright spot in the industrial hemp projections.

North America

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

South America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of south america

Middle East and Africa

  • Saudi Arabia
  • United Arab Emirates
  • Egypt
  • South Africa
  • Rest of MEA

Get full access to the report: https://brandessenceresearch.com/agriculture/industrial-hemp-market-size

Related reports:

Mexico CBD Market Size, Share, and Trend Analysis Report and Forecast, 2021-2027

Cannabidiol Market Size: By Type (hemp-derived type, marijuana-derived type), by application (pharmaceutical industry, food industry, cosmetic industry), forecast 2021 to 2027

Super absorbent polymer (SAP), also known as slush powder, can absorb water up to 300 times its own mass. Due to their highly absorbent water quality, these are often used in gels and the crosslinkers used in SAP provide them with the urgently needed absorption water.

Hemp Milk Market Size, Share and Trend Analysis Report by Source (Organic, Inorganic), by Product (Simple, Flavored, Sweetened, Unsweetened), by Distribution Channel (Supermarket / Hypermarket, Grocery Stores, Online Retail, Other), Region and Segment Forecasts, 2021 – 2027

To achieve quantum computing market size $ 2074.6 million by 2027

Conductive Inks Market Size Is Said To USD. reach $ 3,757.3 million by 2027

The market size of heat exchangers is expected to reach 26.42 billion by 2027

The Air Purifier market size is expected to be $ 21.15 billion by 2027

The advanced wound care market is expected to reach $ 13.27 billion by 2025

Craft Beer to meet market size $ 92.80 billion in 2025

i-Factor: Live Market Intelligence Platform

I-Factor is our guaranteed seal to always give our customers an edge over the competition. This knowledge platform provides real-time updates on key economic indicators, the competitive landscape, changing demand, trends, customer-specific regional insights and more. The platform visualizes important data points in order to make decision-making agile, trustworthy and holistic. Sign up for the free trail here @ https://brandessenceresearch.com/i-factor/login/userRegister

Brandessence Market Research & Consulting Pvt. Ltd.

Brandessence Market Research publishes market research reports and business insights created by highly trained and experienced industry analysts. Our research reports are available in a wide variety of industries including aerospace, food and beverage, healthcare, ICT, construction, chemistry, and more. The Brand Essence market research report is best suited for Executives, Business Development Managers, Marketing Managers, Consultants, CEOs, CIOs, COOs and Directors, Governments, Agencies, Organizations, and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Website: https://brandessenceresearch.com
Blog: Top 5 Air Purifier Manufacturers in the World Market

Mr. Vishal Sawant
E-mail: [email protected]
E-mail: [email protected]
Company sales: + 44-2038074155
Asia office: +917447409162

SOURCE Brandessence Market Research and Consulting Private Limited

Continue Reading

CBD

CBD Kratom Heads West in New York City

Published

on

NS. LOUIS, December 3, 2021 / PRNewswire / – CBD Kratom will open its fifth New York City Store at 2039-B Broadway on the Upper West Side with a soft store opening scheduled for today, 3rd of December followed by an official grand opening event on 10th of December. CBD Kratom is the largest privately owned cannabis and kratom retail chain in The United States.

CBD Kratom looks forward to planting roots in the Upper West Side and joining what is considered one of them New York City best neighborhood.

“The iconic Upper West Side is an ideal neighborhood for us as we continue our expansion into New York City“Said Ocean Cohen, Director of Retail Growth and Development at CBD Kratom. “By adding THC-O to our line of products along with a store in the Upper West Side, we can reach even more people who are looking for wellness solutions. The neighborhood has a relaxed atmosphere and customers will find the same welcoming atmosphere in our store. “

CBD Kratom entered the new York Market on April 20th, the official holiday of the cannabis industry. The company now has branches at the following locations:

  • Chelsea on 20th of April
  • Lenox Hill in the Upper East Side May 20th
  • Flatiron in the Flatiron District on October 1
  • Midtown Times Square on November 4th
  • Upper West Side 3rd of December

With five locations already, CBD Kratom is huge New York City The expansion is far from complete, with three more stores scheduled to open in SoHo, the Financial District and the Upper East Side in early 2022.

Since opening its first store in 2016, CBD Kratom has expanded rapidly with 47 locations in six major cities across the country: Chicago, Dallas, Houston, New York City, Philadelphia and St. Louis. The company offers more than 600 cannabis products, including CBD, THC-O, CBG, other cannabinoids and more than 50 types of pure kratom and specialty kratom products.

Known for their excellent and bespoke customer service, the fully trained staff at CBD Kratom help customers find the right products for their specific needs.

“Grow ours New York City The footprint is critical and the Upper West Side gives us a significant increase in reach and visibility, “said Cohen.” It’s a diverse neighborhood that attracts a lot of people and we look forward to introducing ourselves and our products to them. In our branches we make sure that everyone finds their fit so that they can sleep well, wake up well and live well. “

ABOUT CBD KRATOM:

CBD Kratom aims to help customers live healthy and fulfilling lives. With a wide range of products including edibles, topical creams, oils, skin care and pet treats, customers are guaranteed to find the right product for their individual needs. CBD Kratom has 47 retail locations across the board Chicago, Dallas, Houston, new York, Philadelphia, and St. Louis. Visit shopcbdkratom.com for more information.

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/cbd-kratom-heads-west-in-new-york-city-301437294.html

SOURCE CBD Kratom

Continue Reading

CBD

Access to medicinal cannabis an issue for both patients and suppliers

Published

on

OPINION: I was lucky enough to spend a few days in the South Island last week, translating an old car from Timaru to Wellington.

Not only did I get to enjoy some of the South Island’s god-given macadams in a 40-year-old GT car, but I also gave myself the chance to stop by some old friends. One of them was Dion, an old family friend who lives in a senior village outside Christchurch.

Dion led an active life and spent 50 years farming in Canterbury and the highlands. He’s a good rider and an even better fisherman, which he did for the next 20 years.

From the rakaia salmon to the monster trout at Benmore and Whitebait Runs in Haast, he survived two wives and had to move to a senior citizen village a few years ago at the age of 88 and suffered from back pain and arthritis physical life as a result of his life.

CHRISTEL YARDLEY AND CHRIS MCKEEN

With the help of donations, Karen and Adam Jeffries buy medicinal cannabis products to help their daughter Zoe control her seizures. They were shocked by some of the prices charged. (Video first released on December 4, 2020)

CONTINUE READING:
* Cannabis use without a prescription is still a crime despite an extenuating stance, experts warn
* Medical cannabis company Taranaki debuts on NZX
* AUT announces research into next generation medical cannabis
* Department reviews regulations as companies fear bankruptcy amid slow-moving medical cannabis program

But what was really difficult for him was the loss of his independence. He made a poor invalid. This resulted in him suffering from panic attacks and high blood pressure. With the help of a few professionals, he tried a variety of antipsychotics to catch up with him. But the side effects were harsh and they didn’t seem to work.

He suffered a panic attack earlier this year when a couple of younger friends visited him. One of them took cannabidoil (CBD) to help her sleep and offered Dion a dropper of the olive oil-like compound.

Doctors are still very careful about prescribing CBD oil.

Unsplash

Doctors are still very careful about prescribing CBD oil.

Although Dion had always enjoyed Speights and a bottle or two of Highland Park, he had never tried cannabis (in any form) in his life. But he thought “what the hell” and stuck the pipette full under his tongue.

Within minutes he began to calm down and control his breathing. He guesses that it was like the scary fog cleared and the sunlight came through.

Dion then went to get some CBD oil. The nursing home was prudent and uniformed. So he went to his doctor. She was also careful as she had never prescribed anything before.

She was in good company. According to the New Zealand Medical Journal, 79 percent of New Zealand family doctors have concerns about prescribing medical cannabis. And it’s not surprising.

Medicinal cannabis plants grown in a high security facility.

DOMINICO ZAPATA / STUFF / Waikato Times

Medicinal cannabis plants grown in a high security facility.

Doctors have little solid research on the benefits of CBD oil (or tinctures or creams) and have a legal and ethical obligation not to cause harm.

Dion then spoke to the local chemist. He was surprised to find the chemist was happy to supply it after finding an approved supplier shortly after the medical cannabis program went into effect last April.

An old hippie neighbor at the nursing home told Dion she could pair him up with the local “green fairy”, but that sounded questionable. And Dion is not a seedy man.

In the end, he found a doctor in Wellington who was among the 21 percent of doctors who were happy to provide medicinal cannabis to patients, and he specifically thought that CBD oil could help Dion and not negatively affect the other drugs that he took, would react.

Mike O'Donnell:

Kevin stent / stuff

Mike O’Donnell: “According to the New Zealand Medical Journal, 79 percent of New Zealand general practitioners have concerns about prescribing medical cannabis.”

A Zoom consultation then resulted in the CBD doctor writing to Dion’s doctor and the nursing home endorsing an initial 25 milliliter bottle. And finally Dion got his dope bottle.

The good news is that it assumes it will work and with no side effects. The bad news is that this process took most of three months to complete.

This is bad for the patients and bad for a young local industry in which around 40 companies are trying to gain a foothold.

If you or someone you know thinks that CBD oil could help with pain management, mental health, or insomnia, what’s the best approach? From what I’ve been able to find out, there are four basic steps.

Do your research first. Find solid evidence that CBD (in a specific format) combats the symptoms or the cause of the disease. Also speak to local pharmacies to confirm they have access to the products.

Local medical cannabis company Ora Pharm offers an online portal that is helpful for making evidence-based decisions about the use of medical cannabis. There’s also a pretty handy app out there for incorporating CBD oil into your overall health care routine.

Second, email your GP with the results of your research and your desire to test the drug. Note that for a year now, medical cannabis in the form of CBD has been able to be prescribed for medical conditions. Make it clear that you are not looking for products that contain THC.

PRIME

The cultivation of dope follows New Zealand-based medical cannabis company Rua Bioscience.

Third, make an appointment with this family doctor to clarify your case. Probably a double appointment so that the discussion is not rushed. Everything is going well, they will agree to a little test so see how it goes.

If your general practitioner is not convinced that it is in your best interests, find another general practitioner. Right now I can’t find a website that will do this for you. So you have to do a little research online or chat with the Medical Cannabis Council.

He’s no fool, but dear old Dion thinks this stuff works. And he’s not the only one.

Now the only thing left is for the system to normalize to ensure that patients receive the benefits and that the young local industry can go on and thrive.

– Mike “MOD” O’Donnell is a professional director, writer, and host. His twitter handle is @modsta and he prefers Highland Park Hooter.

Continue Reading
Advertisement

Trending